Van Hulzen Asset Management’s ResMed RMD Stock Holding History

Van Hulzen Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-26,415	Closed	-$1.67M	–	166
2016 Q2	$1.67M	Sell	26,415 -845	-3%	-$49.8K	0.95%	42
2016 Q1	$1.58M	Sell	27,260 -52,865	-66%	-$2.99M	0.9%	44
2015 Q4	$4.3M	Sell	80,125 -1,025	-1%	-$57.8K	2.68%	5
2015 Q3	$4.13M	Buy	+81,150	New	+$4.37M	2.67%	6

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Van Hulzen Asset Management's RMD Position: Q3 2016 in Review

Van Hulzen Asset Management sold out of ResMed (RMD) in Q3 2016, closing a stake of 26,415 shares — an estimated $1.67M sold.

Van Hulzen Asset Management first reported a position in RMD in Q3 2015 and held it in 4 quarters. The position peaked at $4.3M in Q4 2015. 373 funds tracked by Wall St. Rank hold RMD as of Q3 2016.

Van Hulzen Asset Management reported no remaining ResMed position as of Q3 2016 after selling out during the quarter.
Van Hulzen Asset Management sold 26,415 ResMed shares in Q3 2016, an estimated $1.67M.
Van Hulzen Asset Management first reported a position in ResMed in Q3 2015 and held it in 4 quarters.
Van Hulzen Asset Management's ResMed position peaked at $4.3M in Q4 2015.
373 funds tracked by Wall St. Rank held ResMed as of Q3 2016.

Based on Van Hulzen Asset Management's 13F filing for Q3 2016, filed 3 Nov 2016.